Summit Therapeutics Inc. News
Summit Therapeutics Stock Gets Smoked After IPO Pricing
Summit Therapeutics and Epizyme are raising cash to fund new drug development.
Summit Therapeutics Soars on Sarepta Deal
Summit Therapetuics shares skyrocketed Tuesday on word that it has entered into an exclusive licensing agreement with drugmaker Sarepta Therapeutics.
Summit Therapeutics (SMMT) Stock Spikes on Sarepta Licensing Deal
Summit Therapeutics (SMMT) and Sarepta Therapeutics (SRPT) entered an exclusive agreement on Tuesday giving Sarepta rights to Summit's pipeline in several European countries.
IPO Market 'Has Been a Lonely Place' but Pace Is Picking Up
Etsy and Virtu made a quite a splash with their Nasdaq debuts this week but is it enough to bring the U.S. IPO market out of its 2015 lull?
Robbie Stephens Conference: Dallas Presses the iButton
The company sees a bright future in its iButton chip. Also, items on Summit Design and AOL.
Breaking News
Bullish Tesla CEO Musk Pushes Case for Big 2023 Gains: Stock Soars
'If it's a smooth year ... without some big supply chain interruption or massive problem, [we] have the potential to do 2 million cars this year,' Musk says
IBM Stock Slides After Muted Q4 Earnings; 3,900 Job Cuts Planned
"For 2023, we again expect solid growth in our two most important measures of success: revenue and free cash flow," said CFO Jim Kavanaugh.
Southwest Airlines Flight Cancellation Chaos Hits Outlook
"I am deeply sorry for the impact to our employees and customers," said Southwest CEO Bob Jordan.
Comcast Ad Sales, Theme Parks, Payout Boost Offset Broadband Losses
"We achieved these results while continuing to invest in broadband, our 10G network evolution, Xfinity Mobile, Peacock, and theme parks, and we also took cost actions to further our growth in the future," said CEO Brian Roberts.